Takahashi K et al. |
Tacrolimus therapy for ABO-incompatible kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636495
|
Braun F et al. |
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636496
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|
Kinukawa T et al. |
Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. |
1998 |
Transplant. Proc. |
pmid:9636498
|
Morris-Stiff G et al. |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636499
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Turner CD et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. |
1998 |
Transplant. Proc. |
pmid:9636501
|
Carl S et al. |
Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept. |
1998 |
Transplant. Proc. |
pmid:9636502
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|
Friemann S et al. |
Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636504
|
Fernando ON et al. |
Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636505
|
Morris-Stiff G et al. |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report. |
1998 |
Transplant. Proc. |
pmid:9636506
|
Busque S et al. |
Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636507
|
Loss GE et al. |
Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. |
1998 |
Transplant. Proc. |
pmid:9636508
|
Kliem V et al. |
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9636509
|
Copley JB et al. |
Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. |
1998 |
Transplant. Proc. |
pmid:9636510
|
Jordan ML et al. |
Tacrolimus for rescue of refractory renal allograft rejection. |
1998 |
Transplant. Proc. |
pmid:9636511
|
Undre NA and Schäfer A |
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. |
1998 |
Transplant. Proc. |
pmid:9636512
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
van Duijnhoven E et al. |
Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data. |
1998 |
Transplant. Proc. |
pmid:9636514
|